4933403O03Rik Inhibitors

Chemical inhibitors classified as DUXF3 Inhibitors are compounds that can interfere with the function or expression of the DUXF3 protein or its homologs and related pathways. These inhibitors do not directly target DUXF3 but can exert an indirect influence on its activity by modulating various cellular signaling pathways and processes. For example, compounds such as Lithium Chloride, SB-216763, and CHIR99021 inhibit glycogen synthase kinase 3 (GSK-3), which is involved in the Wnt signaling pathway, a key regulatory pathway that can influence the expression or activity of DUXF3. By altering the dynamics of Wnt/β-catenin signaling, these GSK-3 inhibitors can indirectly modulate the role of DUXF3 in transcriptional regulation.

Other chemical classes that can have an impact on DUXF3 include inhibitors of the mTOR pathway, such as Rapamycin, which can affect protein synthesis and thus potentially affect DUXF3's stability or expression levels. MEK inhibitors like PD98059 and U0126 can disrupt the MAPK/ERK pathway, which plays a significant role in cell growth and differentiation and may have a downstream effect on DUXF3-related transcription factors. Inhibitors targeting the JNK pathway, PI3K/AKT pathway, and autophagy, such as SP600125, LY294002, Wortmannin, and SMER28, respectively, can also influence the cellular environment of DUXF3. Additionally, compounds like XAV-939, which promotes β-catenin degradation, can impact the signaling environment of DUXF3.